Telfast vs Otrivin
A side-by-side look at two allergy medications advertised on TV. Informational only — not medical advice.
| NZ Telfast | NZ Otrivin | |
|---|---|---|
| Generic name | fexofenadine | xylometazoline |
| Drug class | Second-Generation Antihistamine | Topical Decongestant |
| Treats | Hay fever, allergic rhinitis, hives | Nasal congestion, cold and sinus relief |
| Category | Allergy | Allergy |
| Manufacturer | Sanofi | Haleon |
| Year approved | 1996 | 1959 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $4M | $3M |
| Common side effects | Headache, Nausea, Dizziness, Drowsiness (uncommon) | Rebound congestion with overuse, Nasal dryness, Stinging, Sneezing |
Frequently asked questions
Is Telfast or Otrivin better?
Neither is universally "better." Telfast (fexofenadine) and Otrivin (xylometazoline) are both used for allergy, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Telfast and Otrivin?
Telfast is a Second-Generation Antihistamine made by Sanofi, while Otrivin is a Topical Decongestant made by Haleon. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Telfast has the larger estimated TV advertising budget of the two.